Byline: Will Doss
-
Faculty Share Expertise on Continuing COVID-19 Response Efforts
According to several recent editorials published by Feinberg faculty, there are large and complex issues to grapple with, from COVID-19’s devastating impact on African-Americans to maintaining critical care standards in the face of an unprecedented pandemic.
-
New Neural Connections Between Thalamus and Cortex
A Northwestern Medicine study has identified looped neural connections between the cortex and thalamus, providing a new understanding of connectivity between the two brain regions.
-
Compound Influences Age-Related Decline in Circadian Rhythms
Supplementing lab animal diets with a chemical precursor of the molecule NAD+ countered certain age-related declines in circadian rhythm function, according to a recent study.
-
Muscle Synergy Helps Maintain Joint Balance
The nervous system groups sets of muscles producing opposing forces on joints, firing the muscles simultaneously to ensure joints aren’t stressed or injured by unbalanced forces, according to a recent study.
-
Origin of Cancer Cells Influences Skin Cancer Prognosis
A new Northwestern Medicine study found important differences in rare skin lymphomas stemming from their specific cell of origin and clinical presentations, according to findings published in Nature Communications.
-
New Function for Transcriptional Regulator Discovered
A new Northwestern Medicine study discovered a new and unexpected function for the transcriptional regulator MLL2/COMPASS.
-
Memory-Related Signaling May Influence Anxiety and Substance Misuse
Neural signaling that encodes certain memories as negative could impact anxiety and substance misuse disorders, according to a recent study.
-
High Blood Pressure Associated with Cognitive Decline in African American Patients
Higher cumulative blood pressure among African-American patients is a major contributor to their higher risk of dementia, according to a new study.
-
Stupp Honored for Contributions to Nanoscience
Samuel Stupp, PhD, was awarded the 2020 Nanoscience Prize from the International Society for Nanoscale Science, Computation and Engineering.
-
First Trial Shows Benefit for Genomically Targeted Prostate Cancer Treatment
For the first time, advanced prostate cancer has been treated based on the genomic makeup of the cancer, delaying disease progression for patients with a treatment-resistant form of prostate cancer.
